Mylan (MYL) Sued by Shareholder Over EpiPen Payments
- AT&T (T) Agrees to Acquire Time Warner (TWX) for More than $80 Billion - WSJ
- Top 10 News for 10/17 - 10/21: Merger Rumors Abound; CEOs Depart; Tesla Kicks Autopilot Up A Notch
- Wall Street ends little changed; Microsoft hits record
- AT&T (T) in Advanced Talks to Acquire Time Warner (TWX) - DJ
- Rockwell Automation (ROK) Said to Attract Takeover Interest from Schneider Electric - Source
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Mylan (NASDAQ: MYL) shares are on watch after an investor sued the company over allegations that it made misstatements on payments made to government health-insurance programs with respect to its EpiPen product, according to Bloomberg.
The lawsuit was filed in Manhattan court Tuesday.
Shares of Mylan are down around 1 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Theravance Biopharma and Mylan Announce Positive Results from Two Pivotal Phase 3 Studies of Revefenacin (TD-4208) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
- SunEdison (SUNEQ) creditors sue dozens of lenders over January deals; want 'hundreds of millions' back - Bloomberg
- Senator Blumenthal says DoJ should reject Mylan (MYL) settlement - Bloomberg
Create E-mail Alert Related CategoriesInsiders' Blog, Litigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!